Myocardial contrast echocardiography has the potential for the assessment of coronary microvascular reserve

Sanjiv Kaul, Ananda R. Jayaweera

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Coronary vasodilators increase coronary flow by increasing myocardial blood volume. Diseases affecting the coronary microvasculature will affect vasodilator-induced changes in coronary flow by inhibiting changes in myocardial blood volume. In such cases, when myocardial time-intensity curves after administration of a vasodilator are compared with those at baseline, a less than anticipated increase in microbubble transit rates will be noted. As long as we understand what we are measuring in the context of where and how we inject the bubbles, we can begin to define the role of myocardial contrast echocardiography in assessing changes in coronary microvascular reserve. It is also conceivable that because myocardial contrast echocardiography can assess changes in myocardial flow/volume relations rather than just changes in flow, this technique could be used to provide additional insights into the mechanisms of action of different coronary vasodilators and into the pathophysiology of various diseases affecting the coronary microvasculature. Finally, with the advent of commercially available microbubbles, robust on- and off-line analysis algorithms and intracardiac imaging, myocardial contrast echocardiography may become an invaluable adjunct to coronary angiography for determining the pathophysiologic significance of coronary disease in individual patients.

Original languageEnglish (US)
Pages (from-to)356-358
Number of pages3
JournalJournal of the American College of Cardiology
Volume21
Issue number2
DOIs
StatePublished - 1993
Externally publishedYes

Fingerprint

Vasodilator Agents
Echocardiography
Coronary Disease
Microbubbles
Microvessels
Blood Volume
Coronary Angiography

ASJC Scopus subject areas

  • Nursing(all)

Cite this

Myocardial contrast echocardiography has the potential for the assessment of coronary microvascular reserve. / Kaul, Sanjiv; Jayaweera, Ananda R.

In: Journal of the American College of Cardiology, Vol. 21, No. 2, 1993, p. 356-358.

Research output: Contribution to journalArticle

@article{522a92f182114ad78f47f63bbe3e5ad5,
title = "Myocardial contrast echocardiography has the potential for the assessment of coronary microvascular reserve",
abstract = "Coronary vasodilators increase coronary flow by increasing myocardial blood volume. Diseases affecting the coronary microvasculature will affect vasodilator-induced changes in coronary flow by inhibiting changes in myocardial blood volume. In such cases, when myocardial time-intensity curves after administration of a vasodilator are compared with those at baseline, a less than anticipated increase in microbubble transit rates will be noted. As long as we understand what we are measuring in the context of where and how we inject the bubbles, we can begin to define the role of myocardial contrast echocardiography in assessing changes in coronary microvascular reserve. It is also conceivable that because myocardial contrast echocardiography can assess changes in myocardial flow/volume relations rather than just changes in flow, this technique could be used to provide additional insights into the mechanisms of action of different coronary vasodilators and into the pathophysiology of various diseases affecting the coronary microvasculature. Finally, with the advent of commercially available microbubbles, robust on- and off-line analysis algorithms and intracardiac imaging, myocardial contrast echocardiography may become an invaluable adjunct to coronary angiography for determining the pathophysiologic significance of coronary disease in individual patients.",
author = "Sanjiv Kaul and Jayaweera, {Ananda R.}",
year = "1993",
doi = "10.1016/0735-1097(93)90675-Q",
language = "English (US)",
volume = "21",
pages = "356--358",
journal = "Journal of the American College of Cardiology",
issn = "0735-1097",
publisher = "Elsevier USA",
number = "2",

}

TY - JOUR

T1 - Myocardial contrast echocardiography has the potential for the assessment of coronary microvascular reserve

AU - Kaul, Sanjiv

AU - Jayaweera, Ananda R.

PY - 1993

Y1 - 1993

N2 - Coronary vasodilators increase coronary flow by increasing myocardial blood volume. Diseases affecting the coronary microvasculature will affect vasodilator-induced changes in coronary flow by inhibiting changes in myocardial blood volume. In such cases, when myocardial time-intensity curves after administration of a vasodilator are compared with those at baseline, a less than anticipated increase in microbubble transit rates will be noted. As long as we understand what we are measuring in the context of where and how we inject the bubbles, we can begin to define the role of myocardial contrast echocardiography in assessing changes in coronary microvascular reserve. It is also conceivable that because myocardial contrast echocardiography can assess changes in myocardial flow/volume relations rather than just changes in flow, this technique could be used to provide additional insights into the mechanisms of action of different coronary vasodilators and into the pathophysiology of various diseases affecting the coronary microvasculature. Finally, with the advent of commercially available microbubbles, robust on- and off-line analysis algorithms and intracardiac imaging, myocardial contrast echocardiography may become an invaluable adjunct to coronary angiography for determining the pathophysiologic significance of coronary disease in individual patients.

AB - Coronary vasodilators increase coronary flow by increasing myocardial blood volume. Diseases affecting the coronary microvasculature will affect vasodilator-induced changes in coronary flow by inhibiting changes in myocardial blood volume. In such cases, when myocardial time-intensity curves after administration of a vasodilator are compared with those at baseline, a less than anticipated increase in microbubble transit rates will be noted. As long as we understand what we are measuring in the context of where and how we inject the bubbles, we can begin to define the role of myocardial contrast echocardiography in assessing changes in coronary microvascular reserve. It is also conceivable that because myocardial contrast echocardiography can assess changes in myocardial flow/volume relations rather than just changes in flow, this technique could be used to provide additional insights into the mechanisms of action of different coronary vasodilators and into the pathophysiology of various diseases affecting the coronary microvasculature. Finally, with the advent of commercially available microbubbles, robust on- and off-line analysis algorithms and intracardiac imaging, myocardial contrast echocardiography may become an invaluable adjunct to coronary angiography for determining the pathophysiologic significance of coronary disease in individual patients.

UR - http://www.scopus.com/inward/record.url?scp=0027401255&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027401255&partnerID=8YFLogxK

U2 - 10.1016/0735-1097(93)90675-Q

DO - 10.1016/0735-1097(93)90675-Q

M3 - Article

C2 - 8425998

AN - SCOPUS:0027401255

VL - 21

SP - 356

EP - 358

JO - Journal of the American College of Cardiology

JF - Journal of the American College of Cardiology

SN - 0735-1097

IS - 2

ER -